Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Interventional Cardiology
When is a reasonable amount of time for patients to be on 90mg BID of ticagrelor before transitioning to 60mg BID following PCI?
Related Questions
What is your preferred P2Y12 inhibitor to use upstream of STEMI cases, if you decide to administer an agent before proceeding to the cath lab?
Do you avoid high-potency P2Y12 inhibitors in favor of clopidogrel in patients with atrial fibrillation on a DOAC who undergo PCI?
What is your preferred duration for triple therapy post-PCI in patients on systemic anticoagulation?
When do you consider revascularizing chronic total occlusions after failing medical management?
Do you recommend routine use of protamine for hemostasis at the end of a transfemoral TAVI?
What has been your approach to percutaneous intervention for calcified nodules and threshold for intervention?
Is there any difference between colchicine 0.5mg vs 0.6 mg for high risk coronary artery disease?
How do you approach the decision of when to perform left heart catheterization in a patient with an NSTEMI who recently had an acute ischemic stroke?
What has been your approach to minimizing the risk of vascular complications when placing Impella support devices?
What type of DES should you opt for if a patient has or is concerned about possible nickel allergy?
